Latest Insider Transactions at Praxis Precision Medicines, Inc. (PRAX)
This section provides a real-time view of insider transactions for Praxis Precision Medicines, Inc. (PRAX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Praxis Precision Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Praxis Precision Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2024
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,800
+39.12%
|
-
|
|
Jul 29
2024
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+41.18%
|
-
|
|
Jul 29
2024
|
Alex Nemiroff General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,800
+41.58%
|
-
|
|
May 14
2024
|
Marcio Souza Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,718
+9.23%
|
$20,616
$12.37 P/Share
|
|
May 14
2024
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
606
+12.25%
|
$7,272
$12.37 P/Share
|
|
Feb 12
2024
|
Marcio Souza Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-1.75%
|
$11,924
$44.65 P/Share
|
|
Feb 12
2024
|
Alex Nemiroff General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-1.59%
|
$2,244
$44.65 P/Share
|
|
Feb 12
2024
|
Lauren Mastrocola Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48
-2.43%
|
$2,112
$44.65 P/Share
|
|
Jan 07
2024
|
Marcio Souza Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
418
-2.63%
|
$10,450
$25.19 P/Share
|
|
Jan 07
2024
|
Alex Nemiroff General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
89
-2.7%
|
$2,225
$25.19 P/Share
|
|
Jan 07
2024
|
Timothy Edwin Kelly Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
139
-3.59%
|
$3,475
$25.19 P/Share
|
|
Jan 07
2024
|
Lauren Mastrocola Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-1.74%
|
$875
$25.19 P/Share
|
|
Oct 05
2023
|
Jill De Simone Director |
BUY
Open market or private purchase
|
Direct |
14,500
+50.0%
|
$14,500
$1.75 P/Share
|
|
Jun 27
2023
|
Marcio Souza Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+18.18%
|
$10,000
$1.06 P/Share
|
|
May 12
2023
|
Marcio Souza Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,687
+4.68%
|
$0
$0.88 P/Share
|
|
May 12
2023
|
Alex Nemiroff General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
11,686
+19.11%
|
$0
$0.88 P/Share
|
|
May 12
2023
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,683
+16.74%
|
$0
$0.88 P/Share
|
|
Mar 24
2023
|
Timothy Edwin Kelly Chief Financial Officer |
SELL
Open market or private purchase
|
Direct |
8,000
-14.7%
|
$0
$0.87 P/Share
|
|
Mar 24
2023
|
Dean J Mitchell Director |
BUY
Open market or private purchase
|
Direct |
50,000
+40.0%
|
$0
$0.84 P/Share
|
|
Mar 23
2023
|
Marcio Souza Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
35,001
+50.0%
|
$0
$0.86 P/Share
|
|
Mar 23
2023
|
Marcio Souza Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
35,000
+13.39%
|
$0
$0.86 P/Share
|
|
Feb 12
2023
|
Nicole Sweeny Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,456
-3.63%
|
$4,368
$3.94 P/Share
|
|
Feb 12
2023
|
Alex Nemiroff General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
920
-2.38%
|
$2,760
$3.94 P/Share
|
|
Feb 12
2023
|
Lauren Mastrocola Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-2.3%
|
$2,133
$3.94 P/Share
|
|
Jan 07
2023
|
Nicole Sweeny Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,079
-4.93%
|
$4,158
$2.52 P/Share
|
|
Jan 07
2023
|
Timothy Edwin Kelly Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,079
-5.13%
|
$4,158
$2.52 P/Share
|
|
Jan 07
2023
|
Lauren Mastrocola Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
520
-1.66%
|
$1,040
$2.52 P/Share
|
|
Jan 07
2023
|
Alex Nemiroff General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,335
-3.34%
|
$2,670
$2.52 P/Share
|
|
Nov 14
2022
|
Alex Nemiroff General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
682
+1.68%
|
$682
$1.81 P/Share
|
|
Nov 14
2022
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.01%
|
$5
$1.81 P/Share
|
|
Nov 14
2022
|
Marcio Souza Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,115
+1.09%
|
$2,115
$1.81 P/Share
|
|
Jun 16
2022
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+8.72%
|
$3,000
$1.92 P/Share
|
|
Jun 13
2022
|
Alex Nemiroff General Counsel and Secretary |
BUY
Open market or private purchase
|
Direct |
7,500
+16.01%
|
$7,500
$1.63 P/Share
|
|
Jun 09
2022
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+19.81%
|
$10,000
$1.76 P/Share
|
|
Jun 08
2022
|
Dean J Mitchell Director |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$25,000
$1.81 P/Share
|
|
Jun 08
2022
|
Marcio Souza Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,000
+12.49%
|
$27,000
$1.85 P/Share
|
|
May 13
2022
|
Nicole Sweeny Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,587
+5.78%
|
$20,696
$8.8 P/Share
|
|
May 13
2022
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,585
+7.82%
|
$20,680
$8.8 P/Share
|
|
May 13
2022
|
Marcio Souza Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,392
+0.85%
|
$11,136
$8.8 P/Share
|
|
May 13
2022
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,557
+8.26%
|
$20,456
$8.8 P/Share
|
|
May 13
2022
|
Alex Nemiroff General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,202
+6.47%
|
$17,616
$8.8 P/Share
|
|
Feb 12
2022
|
Lauren Mastrocola Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
584
-2.21%
|
$7,008
$12.85 P/Share
|
|
Feb 12
2022
|
Alex Nemiroff General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
755
-2.48%
|
$9,060
$12.85 P/Share
|
|
Feb 12
2022
|
Bernard Ravina Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,057
-2.98%
|
$36,684
$12.85 P/Share
|
|
Feb 12
2022
|
Nicole Sweeny Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,233
-3.02%
|
$14,796
$12.85 P/Share
|
|
Jan 07
2022
|
Timothy Edwin Kelly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+46.24%
|
-
|
|
Jan 07
2022
|
Lauren Mastrocola Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+18.51%
|
-
|
|
Jan 07
2022
|
Alex Nemiroff General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+37.19%
|
-
|
|
Jan 07
2022
|
Bernard Ravina Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+17.67%
|
-
|
|
Jan 07
2022
|
Marcio Souza Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,000
+31.52%
|
-
|